← Browse by Condition
Medical Condition
solid tumor adult
Total Trials
11
Recruiting Now
11
Trial Phases
Phase 1, Phase 2, Phase 1, Phase 2, Phase 3
ClinicalMetric tracks all active clinical trials for solid tumor adult sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — solid tumor adult Clinical Trials
How many clinical trials are currently recruiting for solid tumor adult?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for solid tumor adult, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for solid tumor adult?
solid tumor adult research spans Phase 1 (10 trials), Phase 2 (5 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a solid tumor adult clinical trial?
Eligibility criteria for solid tumor adult trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 10
Phase 2 5
Phase 3 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06228326 Phase 1, Phase 2
Recruiting
Enrollment
250 pts
Location
United States
Sponsor
Krystal Biotech, Inc.
NCT06625775 Phase 1
Recruiting
Enrollment
392 pts
Location
United States, Austr...
Sponsor
TheRas, Inc., d/b/a BBOT (Brid...
NCT04282044 Phase 1
Recruiting
Enrollment
60 pts
Location
United States
Sponsor
BioEclipse Therapeutics
NCT06977737 Phase 1, Phase 2
Recruiting
Enrollment
72 pts
Location
Spain, United Kingdo...
Sponsor
Accession Therapeutics Limited
NCT04842812 Phase 1
Recruiting
Enrollment
40 pts
Location
China
Sponsor
Second Affiliated Hospital of ...
NCT07139990 Phase 1
Recruiting
Enrollment
45 pts
Location
United States
Sponsor
University of Texas Southweste...
NCT06478108 Phase 2, Phase 3
Recruiting
Enrollment
60 pts
Location
China
Sponsor
Second Affiliated Hospital of ...
NCT06380660 Phase 1, Phase 2
Recruiting
Enrollment
298 pts
Location
China
Sponsor
Acerand Therapeutics (Shanghai...
NCT04665206 Phase 1, Phase 2
Recruiting
Enrollment
434 pts
Location
United States, Austr...
Sponsor
Vivace Therapeutics, Inc
NCT06915753 Phase 1
Recruiting
Enrollment
100 pts
Location
United States, Canad...
Sponsor
Tyra Biosciences, Inc
NCT06462794 Phase 1
Recruiting
Enrollment
121 pts
Location
United States
Sponsor
CytomX Therapeutics
Related Conditions
liver cancer (2) lung cancer (2) breast cancer (2) lung cancer non small cell (1) lung cancer metastatic (1) advanced cancer (1) lung cancer nsclc (1) metastatic breast cancer (1) advanced breast cancer (1) her2 mutation related tumors (1) her2 positive metastatic breast cancer (1) kras mutant metastatic colorectal cancer (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology